# France Hydrophobic Interaction Chromatography Market > France Hydrophobic Interaction Chromatography Market Research Report: Size, Share, Trend Analysis By Product and Service (Resins, Columns, Services, Others) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 9.49% - **2024:** $ 31.34 Million - **2025:** $ 34.31 Million - **2035:** $ 85 Million - **Key Players:** GE Healthcare (US), Thermo Fisher Scientific (US), Merck KGaA (DE), Agilent Technologies (US), Bio-Rad Laboratories (US), Waters Corporation (US), Pall Corporation (US), Repligen Corporation (US) **Report ID:** MRFR/MED/54731-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/france-hydrophobic-interaction-chromatography-market-56497 --- ## Market Summary ## **France Hydrophobic Interaction Chromatography Market Overview****:** As per MRFR analysis, the France Hydrophobic Interaction Chromatography Market Size was estimated at 11.28 (USD Million) in 2023.The France Hydrophobic Interaction Chromatography Market Industry is expected to grow from 12.15(USD Million) in 2024 to 30.43 (USD Million) by 2035. The France Hydrophobic Interaction Chromatography Market CAGR (growth rate) is expected to be around 8.705% during the forecast period (2025 - 2035). ### **Key France Hydrophobic Interaction Chromatography Market Trends Highlighted** The France Hydrophobic Interaction Chromatography Market, like the rest of the world, is also witnessing some remarkable trends due to certain market factors. One of the primary factors is the increasing production of biopharmaceuticals in France, especially monoclonal antibodies and recombinant proteins, which propels the market. The existing large biopharmaceutical firms in Paris and Lyon are now implementing sophisticated protein purification methodologies involving advanced chromatography systems due to the increased biopharmaceutical industry’s productivity in these regions. Innovative chromatographic materials that further aid in separation and low-cost operational efficiency can be developed. Endeavors in biotechnology, along with life sciences development policies from the government, allow French biotechnological companies to pursue new domains of application for hydrophobic interaction chromatography. Furthermore, there is a growing collaboration between the industry and middle schools in the leading research institutes of France that work on improving chromatographic techniques for dedicated bioprocessing for bioprocessing chromatography. Recent studies also indicate that there is a higher attempt towards automation and integrating entire systems of chromatography into laboratories that comply with tough laws on productivity and efficiency. France aims at modernizing industrial production units and retaining international competition and focus as the goal shifts to increasing productivity in the region. The French marketplace is embracing these shifts alongside the focus on sustainable practices, using convenience, eco-friendly materials and processes. As a result, the French market is balancing technological developments alongside growth and efficiency needs in hydrophobic interaction chromatography. ## **France Hydrophobic Interaction Chromatography Market Drivers** ### **Growing Biopharmaceutical Industry in France** The biopharmaceutical industry is experiencing substantial growth in France, driven by increased investment in Research and Development (R&D) and the rising demand for novel therapeutics. In recent years, France has emerged as a leading hub for biopharmaceutical manufacturing and innovation, with notable contributions from established organizations like Sanofi and Pierre Fabre. According to a report from the French Ministry of Health, the biopharmaceutical sector is projected to grow at an annual rate of 7.4% over the next decade.This growth is expected to translate into a greater need for advanced purification processes, including Hydrophobic Interaction Chromatography (HIC), which is critical for the separation of biomolecules in drug development. The rise in biopharmaceuticals, which was highlighted in the 2022 Biopharmaceutical Outlook released by France Biotech, indicates that the market for HIC in the France Hydrophobic Interaction Chromatography Market Industry will see a corresponding increase as biopharmaceutical companies seek to improve product yield and quality. ### **Increasing Demand for Monoclonal Antibodies** The demand for monoclonal antibodies (mAbs) is rapidly increasing in France, driven by their effectiveness in treating various diseases such as cancer and autoimmune disorders. Research from the French National Institute of Health and Medical Research (INSERM) indicates that mAbs accounted for over 40% of the biopharmaceutical market in 2022, reflecting a growing reliance on these therapies. The production of mAbs necessitates efficient purification techniques, and hydrophobic interaction chromatography has become a preferred method due to its ability to separate proteins based on hydrophobicity.With organizations like CNRS (National Centre for Scientific Research) pushing forward innovative biomanufacturing technologies, the France Hydrophobic Interaction Chromatography Market is well-positioned to benefit from this trend as mAbs continue to dominate the therapeutic landscape. ### **Rising Focus on Personalized Medicine** The shift towards personalized medicine in France is reshaping the healthcare landscape, necessitating advancements in analytical techniques and purification processes. The French government has implemented several policies to support the development of personalized therapies, including large-scale genomic research initiatives. A report from the French Agency for Medicines and Health Products Safety (ANSM) emphasizes the increasing patient demand for targeted therapies tailored to individual genetic profiles.As a result, the requirement for high-resolution purification methods, such as Hydrophobic Interaction Chromatography, is expected to rise. This shift not only enhances therapeutic efficacy but also has implications for the France Hydrophobic Interaction Chromatography Market Industry as manufacturers seek to optimize processes for personalized products. ## **France Hydrophobic Interaction Chromatography Market Segment Insights****:** ### **Hydrophobic Interaction Chromatography Market Product and Service Insights** The Product and Service segment of the France Hydrophobic Interaction Chromatography Market is an essential component in the separation and purification processes crucial for the biotechnology and pharmaceutical industries. This segment encompasses various solutions, including Resins, Columns, Services, and Others, which collectively facilitate improved analytical performance and process efficiency. Resins are particularly significant as they play a crucial role in the interaction with hydrophobic biomolecules, ensuring optimal separation and high yield rates. Columns, designed specifically for hydrophobic interaction chromatography, serve as the medium where the actual separation of biomolecules takes place; hence, they are integral to the process. In addition to resins and columns, the Services aspect provides critical support, offering technical expertise and custom solutions tailored to specific customer requirements, which enhances operational efficiency and reduces costs.  The Others category includes ancillary products and technologies that contribute to the overall efficacy of hydrophobic interaction chromatography, adding value and flexibility to laboratory operations. The increasing focus on biopharmaceuticals has further stimulated the demand for innovative and efficient product offerings within this segment. In France, the growing investments in Research and Development in the life sciences sector are driving advancements in chromatography, thereby enhancing the importance of each category within the Product and Service segment. Coupled with stringent regulatory requirements and the need for high-quality production processes, the segment is expected to show robust growth and innovation, aligning with the increasing trends of bioprocessing and personalized medicine. As the landscape of the industry evolves, stakeholders will continually seek upgraded methodologies that offer enhanced performance, underscoring the pivotal role of the Product and Service segment in the French Hydrophobic Interaction Chromatography Market. ## **France Hydrophobic Interaction Chromatography Market Key Players and Competitive Insights****:** The France Hydrophobic Interaction Chromatography Market has experienced robust growth in recent years, driven by the increasing demand for efficient separation techniques in biopharmaceuticals, research, and other biotechnology applications. The competitive landscape is marked by a variety of players, each vying for market share through innovation, strategic alliances, and an enhanced product portfolio. Additionally, the market is characterized by continuous advancements in chromatographic technology, leading to better performance, increased specificity, and improved yield of desired products.  As regulatory frameworks evolve in the region, companies are increasingly focused on compliance and validation of their processes, thereby contributing to a dynamic competitive environment.Agilent Technologies holds a significant position in the France Hydrophobic Interaction Chromatography Market, attributed to its extensive product offerings and strong brand reputation. The company has been able to leverage its advanced technologies and analytical capabilities, thus enhancing its market penetration in France. Agilent's strengths include its robust R&D infrastructure and a commitment to delivering high-quality solutions that cater specifically to the needs of the local biopharmaceutical sector. Furthermore, the company actively engages in customer education and support services, thus solidifying its relationships with clients and fostering loyalty.  With ongoing investments in technology and infrastructure, Agilent is well-positioned to adapt to the rapidly evolving needs of the French market.Porvair Sciences has also established a solid presence in the France Hydrophobic Interaction Chromatography Market, focusing on specialized products and solutions tailored for the scientific community. The company offers a range of chromatography products, including various types of columns that cater to specific applications within the biopharmaceutical and research sectors. One of its key strengths lies in its commitment to innovation and quality, demonstrated through its continuous product development and enhancements. Porvair Sciences actively seeks strategic partnerships and collaborations to expand its reach and capabilities within the region. The company has engaged in mergers and acquisitions to bolster its product offerings and enhance its market footprint, allowing it to effectively compete in the dynamic landscape of hydrophobic interaction chromatography in France. ### **Key Companies in the France Hydrophobic Interaction Chromatography Market Include:** - Agilent Technologies - Porvair Sciences - Sartorius AG - Merck KGaA - Waters Corporation - Pall Corporation - Fisher Scientific - BioRad Laboratories - Tosoh Bioscience - Danaher Corporation - Thermo Fisher Scientific - MilliporeSigma - New England Biolabs - GE Healthcare - Eppendorf AG ## **France Hydrophobic Interaction Chromatography Market Industry Developments** The France Hydrophobic Interaction Chromatography Market has witnessed several notable developments recently. In September 2023, Agilent Technologies announced advancements in its chromatographic technologies aimed at enhancing separation efficiency and analytical performance, signaling a commitment to remain at the forefront of chromatographic solutions. Meanwhile, Sartorius AG has been expanding its product offerings in France, focusing on innovative techniques that improve bioprocessing workflows. September 2023 also marked significant growth for Merck KGaA in the bioprocessing sector, indicating a rising demand for their advanced chromatography solutions.  There have been discussions surrounding potential mergers, with Pall Corporation and Thermo Fisher Scientific exploring strategic collaborations to strengthen their market positions, although no definitive agreements have been publicly announced. Moreover, the French government's recent investments in biotechnology have further fueled market growth, reflecting a broader trend in France's support for scientific innovation. Over the past few years, there have been significant shifts in market dynamics due to increased demand for purification processes, leading to an enhanced focus on Research and Development (R&D) efforts among leading companies such as BioRad Laboratories and GE Healthcare. The international collaborations in this sector indicate a healthy trajectory for the France Hydrophobic Interaction Chromatography Market. ## **France Hydrophobic Interaction Chromatography Market Segmentation Insights** ### **Hydrophobic Interaction Chromatography Market Product and Service****Outlook** - Resins - Columns - Services - Others ## Market Drivers ### Growing Focus on Quality Control Quality control remains a paramount concern in the pharmaceutical and biopharmaceutical industries in France, significantly impacting the hydrophobic interaction-chromatography market. Regulatory bodies emphasize stringent quality assurance protocols, necessitating the use of reliable purification techniques. HIC is recognized for its ability to provide high purity levels, making it a preferred choice for quality control processes. As companies strive to meet regulatory standards, the demand for HIC is expected to rise. In 2025, the market for quality control solutions in the pharmaceutical sector is projected to grow by 8%, further driving the adoption of hydrophobic interaction-chromatography. This focus on quality not only enhances product safety but also boosts consumer confidence, thereby reinforcing the importance of HIC in the overall manufacturing process. ### Emergence of Personalized Medicine The shift towards personalized medicine in France is influencing the hydrophobic interaction-chromatography market. As healthcare moves towards tailored therapies, the need for precise and efficient purification methods becomes critical. HIC offers the versatility required to isolate specific proteins and biomolecules, aligning with the goals of personalized medicine. The increasing prevalence of chronic diseases and the demand for targeted therapies are likely to propel the growth of the biopharmaceutical sector, which in turn drives the need for advanced chromatographic techniques. By 2025, the personalized medicine market in France is anticipated to reach €3 billion, indicating a substantial opportunity for HIC. This trend suggests that the hydrophobic interaction-chromatography market will play a vital role in supporting the development of customized therapeutic solutions. ### Increasing Biopharmaceutical Production The hydrophobic interaction-chromatography market is experiencing growth due to the rising production of biopharmaceuticals in France. As the biopharmaceutical sector expands, the demand for effective purification techniques increases. Hydrophobic interaction chromatography (HIC) is particularly valued for its ability to separate proteins based on their hydrophobic properties, making it essential in the production of therapeutic proteins and monoclonal antibodies. In 2025, the biopharmaceutical market in France is projected to reach approximately €10 billion, indicating a robust growth trajectory. This surge in biopharmaceutical production necessitates advanced purification methods, thereby driving the hydrophobic interaction-chromatography market. The increasing focus on developing novel therapeutics further emphasizes the need for efficient separation technologies, positioning HIC as a critical component in the biopharmaceutical manufacturing process. ### Rising Investment in Research and Development Investment in research and development (R&D) within the life sciences sector in France is a significant driver for the hydrophobic interaction-chromatography market. As pharmaceutical companies and research institutions allocate more resources to R&D, the demand for advanced chromatographic techniques grows. HIC is increasingly utilized in the development of new drugs and therapies, particularly in the biopharmaceutical domain. In 2025, R&D spending in the French pharmaceutical industry is expected to exceed €5 billion, reflecting a commitment to innovation. This investment not only enhances the capabilities of existing purification methods but also fosters the development of novel applications for HIC. Consequently, the hydrophobic interaction-chromatography market is likely to benefit from this trend, as researchers seek efficient and reliable methods for protein purification. ### Technological Integration in Manufacturing Processes The integration of advanced technologies in manufacturing processes is a notable driver for the hydrophobic interaction-chromatography market. Automation and digitalization are transforming the biopharmaceutical manufacturing landscape in France, enhancing efficiency and productivity. HIC is increasingly being integrated with automated systems, allowing for real-time monitoring and optimization of purification processes. This technological advancement not only improves the reliability of HIC but also reduces operational costs. In 2025, the market for automated chromatography systems is projected to grow by 10%, reflecting the industry's shift towards more efficient manufacturing practices. As companies adopt these technologies, the hydrophobic interaction-chromatography market is likely to experience significant growth, driven by the demand for streamlined and cost-effective purification solutions. ## Future Outlook The [Hydrophobic Interaction Chromatography Market](https://www.marketresearchfuture.com/reports/hydrophobic-interaction-chromatography-market-6366) in France is projected to grow at a 9.49% CAGR from 2025 to 2035, driven by increasing biopharmaceutical demand and technological advancements. **New opportunities:** - Development of customized resin solutions for specific applications. - Expansion of online training programs for chromatography techniques. - Partnerships with biopharma companies for integrated purification solutions. By 2035, the market is expected to achieve robust growth, positioning itself as a leader in bioprocessing solutions. ## Segment Insights ### By Product and Service: Resins (Largest) vs. Columns (Fastest-Growing) The market share distribution among the product and service values shows that resins hold the largest share in the France hydrophobic interaction-chromatography market. Their robustness and efficiency in protein purification processes have made them the preferred choice among developers. Columns, while currently having a smaller segment share, are rapidly gaining traction due to the growing demand for more sophisticated chromatographic techniques. The growth trends in this segment are primarily driven by advancements in biopharmaceutical production and increasing research activities in proteomics. As the focus on high-throughput and personalized medicine intensifies, the demand for efficient and reliable columns is expected to grow. This shift signals a movement towards innovative solutions that cater to evolving market needs and enhance productivity. Resins (Dominant) vs. Columns (Emerging) Resins are the dominant players in the France hydrophobic interaction-chromatography market, known for their versatility and effectiveness in separation processes. They are essential for ensuring high purity and yield in biochemical applications, enabling researchers to meet the rigorous demands of modern applications. Columns, on the other hand, although classified as emerging, are experiencing rapid development and adoption. Advances in materials and technology are improving their efficiency and capacity, making them increasingly popular in laboratories. Together, these segment values reflect the dynamic landscape of the industry, where innovation continues to drive significant changes in market preferences. ### By Sample Type: Monoclonal Antibodies (Largest) vs. Others (Fastest-Growing) In the France hydrophobic interaction-chromatography market, Monoclonal Antibodies dominate the sample type segment with a significant market share, driven by increasing demand for biopharmaceuticals and advanced therapeutic solutions. This segment's strength is attributed to its critical role in drug discovery and development, resulting in its substantial presence in the industry. Conversely, the Others segment is emerging rapidly, showcasing the fastest growth due to the diversification of applications in biotechnology and pharmaceuticals. Innovations and advancements in technology, alongside a surge in research initiatives, are propelling this segment forward, indicating a shifting landscape where new sample types gain traction and reshape market dynamics. Monoclonal Antibodies (Dominant) vs. Others (Emerging) Monoclonal Antibodies represent the dominant force in the sample type segment, primarily due to their pivotal utilization in therapeutic and diagnostic applications. Their ability to provide targeted treatment options enhances their appeal, leading to robust market interest and investment. On the other hand, the Others segment is categorized as emerging, reflecting the growth of novel sample types that are gaining visibility and application within the industry. This includes a variety of innovative biological products and methodologies that are becoming increasingly relevant, driven by scientific advancements and shifting regulatory landscapes, thereby enhancing their market presence and creating new opportunities. ### By End-User: Pharmaceutical & Biopharmaceutical Companies (Largest) vs. Contract Research Organizations (Fastest-Growing) The market for hydrophobic interaction-chromatography is significantly shaped by its end-users, which include Pharmaceutical & Biopharmaceutical Companies, Contract Research Organizations (CROs), Research & Academic Institutes, and Others. Among these, Pharmaceutical & Biopharmaceutical Companies hold the largest market share, as these entities heavily invest in advanced chromatographic techniques to enhance drug development and production. In contrast, Contract Research Organizations are emerging as the fastest-growing segment due to the increasing outsourcing of research and development by pharmaceutical companies. This trend is driven by the need for cost efficiency and rapid access to specialized expertise. Additionally, Research & Academic Institutes, while smaller in market share, play a crucial role in driving innovation and research advancements in the field. Pharmaceutical & Biopharmaceutical Companies (Dominant) vs. Contract Research Organizations (Emerging) Pharmaceutical & Biopharmaceutical Companies are the dominant end-users in the hydrophobic interaction-chromatography sector, utilizing these techniques for effective protein purification and characterization, which are pivotal in drug discovery and development. Their deep financial resources allow them to adopt state-of-the-art technologies to enhance productivity and compliance. On the other hand, Contract Research Organizations represent an emerging force in this market. Their rapid growth is attributed to the rising trend of outsourcing in the biopharmaceutical industry, allowing companies to focus on their core competencies while leveraging the specialized services offered by CROs in chromatographic processes. ## Competitive Benchmarking The hydrophobic interaction-chromatography market in France is characterized by a competitive landscape that is increasingly shaped by innovation and strategic partnerships. Key players such as GE Healthcare (US), Thermo Fisher Scientific (US), and Merck KGaA (DE) are actively pursuing strategies that emphasize technological advancements and regional expansion. GE Healthcare (US) appears to be focusing on enhancing its product portfolio through continuous innovation, while Thermo Fisher Scientific (US) is likely leveraging its extensive distribution network to penetrate deeper into the French market. Merck KGaA (DE), on the other hand, seems to be concentrating on sustainability initiatives, which may resonate well with the growing demand for environmentally friendly solutions in the life sciences sector. Collectively, these strategies contribute to a dynamic competitive environment where differentiation is increasingly reliant on technological prowess and sustainability efforts. In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several key players holding substantial market shares. This fragmentation allows for a diverse range of offerings, yet the influence of major companies remains significant, as they set trends and standards that smaller firms often follow. In October 2025, Thermo Fisher Scientific (US) announced the launch of a new line of hydrophobic interaction chromatography columns designed to improve protein purification efficiency. This strategic move is likely to enhance their competitive edge by addressing specific customer needs for higher throughput and better resolution in protein separation. Such innovations not only strengthen their product offerings but also reinforce their position as a leader in the market. In September 2025, Merck KGaA (DE) entered into a strategic partnership with a French biotechnology firm to co-develop advanced chromatography solutions tailored for the local market. This collaboration is indicative of a broader trend where established companies seek to leverage local expertise to enhance their product relevance and market penetration. By aligning with local innovators, Merck KGaA (DE) may effectively navigate regulatory landscapes and customer preferences, thereby solidifying its market presence. In August 2025, GE Healthcare (US) expanded its manufacturing capabilities in France, investing €10 million in a new facility dedicated to the production of chromatography products. This investment underscores the company's commitment to meeting the growing demand for biopharmaceutical manufacturing solutions in Europe. By increasing local production capacity, GE Healthcare (US) is likely to improve supply chain reliability and reduce lead times, which are critical factors in the highly competitive bioprocessing market. As of November 2025, current trends in the hydrophobic interaction-chromatography market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into product development. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and enhancing market responsiveness. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition towards a focus on technological innovation, supply chain reliability, and sustainable practices. This shift may redefine the competitive landscape, compelling companies to invest in R&D and forge strategic partnerships to maintain their market positions. ## Recent News & Developments The France Hydrophobic Interaction Chromatography Market has witnessed several notable developments recently. In September 2023, Agilent Technologies announced advancements in its chromatographic technologies aimed at enhancing separation efficiency and analytical performance, signaling a commitment to remain at the forefront of chromatographic solutions. Meanwhile, Sartorius AG has been expanding its product offerings in France, focusing on innovative techniques that improve bioprocessing workflows. September 2023 also marked significant growth for Merck KGaA in the bioprocessing sector, indicating a rising demand for their advanced chromatography solutions.  There have been discussions surrounding potential mergers, with Pall Corporation and Thermo Fisher Scientific exploring strategic collaborations to strengthen their market positions, although no definitive agreements have been publicly announced. Moreover, the French government's recent investments in biotechnology have further fueled market growth, reflecting a broader trend in France's support for scientific innovation. Over the past few years, there have been significant shifts in market dynamics due to increased demand for purification processes, leading to an enhanced focus on Research and Development (R&D) efforts among leading companies such as BioRad Laboratories and GE Healthcare. The international collaborations in this sector indicate a healthy trajectory for the France Hydrophobic Interaction Chromatography Market. ## Report Scope | MARKET SIZE 2024 | 31.34(USD Million) | | --- | --- | | MARKET SIZE 2025 | 34.31(USD Million) | | MARKET SIZE 2035 | 85.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.49% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | GE Healthcare (US), Thermo Fisher Scientific (US), Merck KGaA (DE), Agilent Technologies (US), Bio-Rad Laboratories (US), Waters Corporation (US), Pall Corporation (US), Repligen Corporation (US) | | Segments Covered | Product and Service, Sample Type, End-User | | Key Market Opportunities | Advancements in biopharmaceuticals drive demand for innovative solutions in the hydrophobic interaction-chromatography market. | | Key Market Dynamics | Rising demand for biopharmaceuticals drives innovation in hydrophobic interaction-chromatography technologies and applications. | | Countries Covered | France | ## Frequently Asked Questions **Q: What is the current valuation of the hydrophobic interaction-chromatography market in France?** A: The market valuation was $31.34 Million in 2024. **Q: What is the projected market size for hydrophobic interaction-chromatography in France by 2035?** A: The projected market size is $85.0 Million by 2035. **Q: What is the expected CAGR for the hydrophobic interaction-chromatography market in France during 2025 - 2035?** A: The expected CAGR is 9.49% during the forecast period. **Q: Which companies are the key players in the hydrophobic interaction-chromatography market in France?** A: Key players include GE Healthcare, Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Bio-Rad Laboratories, Waters Corporation, Pall Corporation, and Repligen Corporation. **Q: What are the main product segments in the hydrophobic interaction-chromatography market in France?** A: Main product segments include Resins, Columns, Buffers, and Other Products and Services. **Q: How did the revenue from Resins in the hydrophobic interaction-chromatography market perform in 2024?** A: Revenue from Resins was between $8.0 Million and $21.0 Million in 2024. **Q: What is the revenue range for Monoclonal Antibodies in the hydrophobic interaction-chromatography market?** A: The revenue range for Monoclonal Antibodies was $10.0 Million to $25.0 Million in 2024. **Q: Which end-user segments are driving the hydrophobic interaction-chromatography market in France?** A: Driving end-user segments include Pharmaceutical & Biopharmaceutical Companies, Contract Research Organizations, and Research & Academic Institutes. **Q: What was the revenue from Vaccines in the hydrophobic interaction-chromatography market in 2024?** A: The revenue from Vaccines ranged from $15.0 Million to $40.0 Million in 2024. **Q: What is the expected growth trend for the hydrophobic interaction-chromatography market in France?** A: The market is expected to grow significantly, reaching $85.0 Million by 2035, indicating robust demand. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/france-hydrophobic-interaction-chromatography-market-56497*